前收市價 | 4.3500 |
開市 | 4.3400 |
買盤 | 4.1300 x 200 |
賣出價 | 4.1600 x 100 |
今日波幅 | 4.0900 - 4.3700 |
52 週波幅 | 2.0100 - 6.1300 |
成交量 | |
平均成交量 | 987,382 |
市值 | 339.324M |
Beta 值 (5 年,每月) | 1.09 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.7800 |
業績公佈日 | 2024年5月13日 - 2024年5月17日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 12.80 |
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Sutro Biopharma (STRO) delivered earnings and revenue surprises of 151.22% and 834.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Sutro Biopharma (STRO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.